This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

With Haloperidol, Review of 34 Cases

Arthur K. Shapiro, MD; Elaine Shapiro, PhD; Henriette Wayne, MD

Arch Gen Psychiatry. 1973;28(1):92-97.

Abstract
This study of 34 patients with Gilles de la Tourette's syndrome describes the treatment of 21 patients who were followed for two months to five years. Thirteen patients were excluded from the overall analysis because they did not fulfill criteria for inclusion in this report.

Haloperidol was a difficult drug to use effectively. The dosage varied between 6 and 180 mg and had to be titrated against an endpoint of efficacy compared with side effects. Most patients were able to achieve over 90% decrease in their symptoms after one year of treatment. Other minor and major tranquilizers were less effective. Other chemotherapy and psychotherapy were ineffective. Spontaneous decrease or increase of symptoms are common and lead to difficulty in evaluation of clinical course.

Author Affiliations
ScD, New York

From the Special Studies Laboratory, Department of Psychiatry, Payne Whitney Clinic, New York Hospital-Cornell University Medical Center, New York.

Footnotes
Accepted for publication July 3, 1972.

Reprint requests to Special Studies Laboratory, Department of Psychiatry, New York Hospital-Cornell University Medical Center, 525 E 68th St, New York 10021 (Dr. Arthur K. Shapiro).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Integration of Neurology, Psychiatry, and Neuroscience in the 21st Century
Martin
Am. J. Psychiatry 2002;159:695-704.
ABSTRACT | FULL TEXT  

Tourette syndrome, associated conditions and the complexities of treatment
Robertson
Brain 2000;123:425-462.
ABSTRACT | FULL TEXT  

Controlled Study of Haloperidol, Pimozide, and Placebo for the Treatment of Gilles de la Tourette's Syndrome
Shapiro et al.
Arch Gen Psychiatry 1989;46:722-730.
ABSTRACT  

Treatment of Gilles de la Tourette's Syndrome With Clonidine and Neuroleptics
Shapiro et al.
Arch Gen Psychiatry 1983;40:1235-1240.
ABSTRACT  

Effects of Dopamine Agonists and Antagonists in Tourette's Disease
Feinberg and Carroll
Arch Gen Psychiatry 1979;36:979-985.
ABSTRACT  

Tourette's Syndrome Symptom Onset At Age Thirty-Five
Araneta et al.
Int J Soc Psychiatry 1979;25:4-9.
 

Chronic, Multiple Tics of Gilles de la Tourette's Disease: CSF Acid Monoamine Metabolites After Probenecid Administration
Cohen et al.
Arch Gen Psychiatry 1978;35:245-250.
ABSTRACT  

Tourette Syndrome: The Pediatric Perspective
Golden
Arch Pediatr Adolesc Med 1977;131:531-534.
ABSTRACT  

Presynaptic Catecholamine Antagonists as Treatment for Tourette Syndrome: Effects of Alpha Methyl Para Tyrosine and Tetrabenazine
Sweet et al.
Arch Gen Psychiatry 1974;31:857-861.
ABSTRACT